Trial Profile

Pharmacokinetics (PK)/bioequivalence Study of CUREfilm Blue to Treat Erectile Dysfunction (ED)

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 22 Aug 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sildenafil (Primary)
Indications Erectile dysfunction
Focus Adverse reactions; Pharmacokinetics
Sponsors Cure Pharmaceutical

Most Recent Events

17 Aug 2021 According to a Cure Pharmaceutical media release, initial trial results were announced during the second quarter of 2021.
24 Feb 2021 Status changed from planning to recruiting.
23 Feb 2021 According to a Cure Pharmaceutical media release, the IND application has been initiated via the 505(b)(2) drug approval pathway.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com